Drostanolone Tablets
Showing 1–12 of 21 results
Showing 1–12 of 21 results
Oral masteron is one of the least reliable labels in this catalogue
This section holds 21 lines from £32 to £144, averaging near £76. Before anything else: products sold as oral masteron are frequently not oral drostanolone. The most common substitution is methyldrostanolone, known as superdrol, which is a related but meaningfully different compound.
Why the confusion exists
Drostanolone was developed as an injectable. Making it orally active requires structural modification, and the modification used produces methyldrostanolone — a 17-alpha-methylated compound. That methyl group is what makes it survive first-pass metabolism, and it is also what makes it hepatotoxic.
So the “oral version of masteron” is not the same molecule with a different delivery route. It is a distinct compound with a distinct risk profile, and the shared name obscures that.
Why the distinction matters
| Name | What it is |
|---|---|
| Drostanolone propionate | Injectable masteron; not methylated |
| Methyldrostanolone | Superdrol; methylated and hepatotoxic |
| “Oral masteron” | Usually the second, sold under the first’s name |
Injectable masteron is among the gentler compounds on the liver because it bypasses first-pass metabolism entirely. Superdrol is among the harsher compounds in the oral steroids range. Someone buying the second expecting the first has the risk profile badly wrong.
What to check before ordering
Read the actual compound name on the listing rather than the marketing name. If it says methyldrostanolone, methasterone or superdrol, that is what it is — treat it as a strongly hepatotoxic oral, keep the duration short and monitor liver markers.
Anyone wanting drostanolone specifically, with the profile masteron is known for, should be buying the injectable and not an oral at all.
The rest of the profile
Both are DHT-derived, neither aromatises, and both are suppressive enough to need post cycle therapy. Neither is helped by aromatase inhibitors, since there is no aromatisation to inhibit.
Why this matters more than an ordinary labelling quibble
Most naming confusion in this catalogue is cosmetic — a trade name against a compound name, with the same molecule underneath. This one is not. The two products differ in liver toxicity by a wide margin, and someone who bought on the basis of masteron’s mild reputation may be taking one of the harsher orals available without knowing it.
That is a safety issue rather than a semantic one, which is why it sits at the top of this page instead of in a footnote.
Frequently asked questions
Is oral masteron the same as injectable masteron?
Usually not. Products under that name are commonly methyldrostanolone, a methylated and hepatotoxic compound.
How do I tell which I am buying?
Read the compound name. Methyldrostanolone, methasterone and superdrol all mean the harsher oral.
Why is the oral harder on the liver?
The 17-alpha-methyl group that lets it survive first-pass metabolism is what causes the strain.
Do I need an aromatase inhibitor?
No. Neither compound aromatises, so there is nothing for an inhibitor to act on.
What if I want the masteron profile specifically?
Buy the injectable. The oral is a different compound with a different risk profile.
